Is it safe to combine Viibryd (vilazodone) and propranolol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Viibryd and Propranolol Combination Safety

Yes, it is safe to combine Viibryd (vilazodone) with propranolol, as there are no significant pharmacokinetic or pharmacodynamic interactions between these medications, and propranolol is well-tolerated in combination with various psychiatric medications including antidepressants. 1

Pharmacological Compatibility

  • No direct drug-drug interactions exist between vilazodone and propranolol, as vilazodone does not significantly inhibit or induce cytochrome P450 enzymes that would affect propranolol metabolism 2
  • Propranolol has demonstrated safety when combined with psychiatric medications, including SSRIs and SNRIs, without significant cardiovascular contraindications 1
  • Vilazodone has minimal cardiac toxicity and does not prolong QT interval, making it compatible with beta-blockers like propranolol 2

Cardiovascular Monitoring Requirements

Before initiating combination therapy:

  • Perform baseline cardiovascular assessment including heart rate and blood pressure 3
  • Check for contraindications to propranolol (asthma, severe bradycardia, heart block, decompensated heart failure) 4

During treatment:

  • Monitor heart rate and blood pressure regularly, especially during the first 30 days of combination therapy 3
  • Watch for symptoms of excessive beta-blockade including dizziness, fatigue, or bradycardia (heart rate <55 bpm) 3
  • Avoid abrupt discontinuation of propranolol to prevent rebound hypertension or tachycardia 3

Dosing Strategy

For vilazodone:

  • Start at 10 mg once daily with food for 7 days, then increase to 20 mg daily for 7 days, then target dose of 40 mg daily 2
  • Dose titration is necessary due to high rate of gastrointestinal side effects (nausea, diarrhea) 2

For propranolol:

  • When adding to established vilazodone therapy, consider starting at 20 mg twice daily 3
  • Titrate to achieve resting heart rate of 55-60 beats per minute if used for conditions like portal hypertension 4
  • For anxiety or other indications, typical dosing is 40-80 mg twice daily 4

Clinical Advantages of This Combination

  • Particularly useful for patients with comorbid conditions such as depression with anxiety, migraine prophylaxis, or essential tremor where both medications have proven efficacy 3
  • Vilazodone has fewer sexual side effects compared to traditional SSRIs, which may improve adherence 2
  • The combination may address both mood symptoms (vilazodone) and physical anxiety symptoms like tachycardia and tremor (propranolol) 5

Important Caveats

  • Elderly patients may be more sensitive to combined cardiovascular effects and should receive lower initial doses of both medications 3
  • Patients with hepatic impairment may require dose adjustments for vilazodone 2
  • The combination does not increase risk of serotonin syndrome, as propranolol is not serotonergic 1
  • Unlike calcium channel blockers (diltiazem, verapamil), propranolol does not carry significant risk of severe bradycardia or heart block when combined with psychiatric medications 6

References

Guideline

Medication Selection for ADHD in Complex Polypharmacy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A review of current evidence for vilazodone in major depressive disorder.

International journal of psychiatry in clinical practice, 2013

Guideline

Combination Therapy with Duloxetine and Propranolol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diazepam, propranolol and their combination in the management of chronic anxiety.

The British journal of psychiatry : the journal of mental science, 1981

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.